Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Brungs"'
Autor:
Joseph W Po, Yafeng Ma, Bavanthi Balakrishna, Daniel Brungs, Farhad Azimi, Paul de Souza, Therese M Becker
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211866 (2019)
Personalised medicine targeted to specific biomarkers such as BRAF and c-Kit has radically improved the success of melanoma therapy. More recently, further advances have been made using therapies targeting the immune response. In particular, therapie
Externí odkaz:
https://doaj.org/article/56cd8d8405ea4c8a89d0237bd6fa3876
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191455 (2018)
In advanced prostate cancer, osteoclast inhibitors prevent and palliate skeletal related events associated with bone metastases. However, it is uncertain whether they play a disease-modifying role earlier in the course of the disease.Medline, EMBASE,
Externí odkaz:
https://doaj.org/article/5b0de5df9a294c89b54cdd53d81ab234
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191455 (2018)
PLoS ONE
PLoS ONE
Background In advanced prostate cancer, osteoclast inhibitors prevent and palliate skeletal related events associated with bone metastases. However, it is uncertain whether they play a disease-modifying role earlier in the course of the disease. Meth
Autor:
Therese M. Becker, Daniel Brungs, Farhad Azimi, Joseph W. Po, Yafeng Ma, Paul de Souza, Bavanthi Balakrishna
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211866 (2019)
PLoS ONE
PLoS ONE
Personalised medicine targeted to specific biomarkers such as BRAF and c-Kit has radically improved the success of melanoma therapy. More recently, further advances have been made using therapies targeting the immune response. In particular, therapie